Syncope in hypertrophic (obstructive) cardiomyopathy

Herzschrittmachertherapie & Elektrophysiologie
Hubert SeggewissMalte Meesmann

Abstract

Hypertrophic cardiomyopathy is the most common genetic cardiac disease. The most important pathophysiological finding is dynamic (outflow tract) obstruction of the left ventricle in about 70% of affected patients. Especially in younger patients, an increased risk of sudden cardiac death has been observed. Syncope and presyncope-in addition to extremely variable cardiac symptoms (dyspnea and angina)-are common. The etiology of syncope is complex. The most important aspect for diagnosis is a detailed history regarding the accompanying circumstances of the syncope. In principle, an attempt must be made to distinguish between rhythmogenic and hemodynamic causes. Diagnostic work-up should be performed under the criteria of a possible prognostic-with implantation of an implantable cardioverter-defibrillator (ICD) in patients at increased risk of sudden cardiac death-and symptomatic therapy. Depending on the underlying morphology and the experience of the surgeon, percutaneous septal ablation and operative myectomy are complementary options for symptomatic treatment if medical therapy with beta-blockers and/or verapamil is inadequate.

References

May 24, 1996·Deutsche medizinische Wochenschrift·U GleichmannS Strick
Jan 24, 2003·The New England Journal of Medicine·Martin S MaronBarry J Maron
May 25, 2007·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Lynne Williams, Michael Frenneaux
May 9, 2009·Pacing and Clinical Electrophysiology : PACE·Majid HaghjooMohammad Ali Sadr-Ameli
Mar 19, 2013·Arquivos brasileiros de cardiologia·Milena Frota Macatrão-CostaDenise Hachul
Oct 16, 2013·European Heart Journal·Constantinos O'MahonyUNKNOWN Hypertrophic Cardiomyopathy Outcomes Investigators
Jun 18, 2014·European Heart Journal·Perry Elliott
Jan 20, 2017·Cardiovascular Ultrasound·Eugenio PicanoPaolo Colonna
Feb 25, 2017·Deutsche medizinische Wochenschrift·Lothar FaberHubert Seggewiss
Sep 16, 2017·Circulation Research·Rick A NishimuraHartzell V Schaff

❮ Previous
Next ❯

Citations

Mar 19, 2020·Herz·Angelika Batzner, Hubert Seggewiß
Mar 12, 2019·Deutsches Ärzteblatt International·Angelika BatznerHubert Seggewiß

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Revue médicale suisse
G Giannakopoulos, C Frangos
The Journal of Thoracic and Cardiovascular Surgery
Hartzell V Schaff, Anita Nguyen
© 2022 Meta ULC. All rights reserved